Home/Adverum Biotechnologies/Carla Fiankan

CF

Carla Fiankan

Senior Vice President, Regulatory Affairs

Adverum Biotechnologies

Therapeutic Areas

Ophthalmology Retinal Diseases

Adverum Biotechnologies Pipeline

Drug	Indication	Phase
Ixoberogene soroparvovec (Ixo-vec)	Neovascular (Wet) Age-Related Macular Degeneration (wAMD)	Phase 3

Leadership Team at Adverum Biotechnologies

Laurent Fischer, M.D.

President and Chief Executive Officer

Romuald Corbau, Ph.D.

Chief Scientific Officer

General Counsel

Chief People Officer

Heikki Jouttijärvi

Senior Vice President, Manufacturing

View full Adverum Biotechnologies profile